How to make your biotech company more valuable

In a tough funding environment, biotechs need to show investors they are creating value, by focusing on reducing risk, shortening the time to market and maximizing peak sales.

Join Chris Ball, one of IQVIA’s biotech client partners, to review ways you can practically address these challenges to position your company for success – whatever the stage of your business.

Chris has over 25 years of experience in life science commercialization, having worked in strategic marketing for Johnson and Johnson, as a venture capital investor and CEO of OPK Biotech, a US commercial-stage biotech company. He is trained in internal medicine from the Universities of Cambridge and Oxford and has an MBA from the Wharton School of Business.

Key Take-aways:

• Understand what evidence regulators, payers and clinicians want to see
• Be clear on your product’s strategic fit, its competitive edge and the implications for your commercialization plans
• Plan in detail to shorten your time to market

@SmiLe Community Room

For: Community members